Sueyoshi T, Negishi M. Phenobarbital response elements of cytochrome P450 genes and
nuclear receptors. Annu Rev Pharmacol Toxicol 2001;41:123–143.
Sumida A, Yamamoto I, Zhou Q, Morisaki T, Azuma J. Evaluation of induction of
CYP3A mRNA using the HepG2 cell line and reverse transcription-PCR. Biol
Pharm Bull 1999;22:61–65.
Thummel KE, Wilkinson GR.In vitroandin vivodrug interactions involving human
CYP3A. Annu Rev Pharmacol Toxicol 1998;38:389–430.
Tsunoda SM, Harris RZ, Mroczkowski PJ, Benet LZ. Preliminary evaluation of
progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women. J
Clin Pharmacol 1998;38:1137–1143.
Tucker GT, Houston JB, Huang SM. Optimizing drug development: strategies to assess
drug metabolism/transporter interaction potential-toward a consensus. Clin
Pharmacol Ther 2001;70:103–114.
Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR. CYP3A activity in
African-American and European-American men: population differences and
functional effect of the CYP3A4^ 1B5^0 -promoter region polymorphism. Clin
Pharmacol Ther 2000;68:82–91.
Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS.
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes
P450. Studies in rats and patients. J Clin Invest 1989;83:688–697.
Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug
metabolism. Crit Rev Toxicol 1992;22:1–21.
Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-
Tetri BA, Brunt EM, Guzelian PS, Evans RM. Humanized xenobiotic response in
mice expressing nuclear receptor SXR. Nature 2000;406:435–439.
Xie W, Evans RM. Pharmaceutical use of mouse models humanized for the xenobiotic
receptor. Drug Discov Today 2002;7:509–515.
Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC. Different alterations
of cytochrome P450 3A4 isoform and its gene expression in livers of patients with
chronic liver diseases. World J Gastroenterol 2003;9:359–363.
Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, Yan B. Rat pregnane X
receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch
Biochem Biophys 1999;368:14–22.
Zhao XJ, Jones DR, Wang YH, Grimm SW, Hall SD. Reversible and irreversible
inhibition of CYP3A enzymes by tamoxifen and metabolites. Xenobiotica
2002;32:863–878.
Zhu Z, Kim S, Chen T, Lin JH, Bell A, Bryson J, Dubaquie Y, Yan N, Yanchunas J,
Xie D, Stoffel R, Sinz M, Dickinson K. Correlation of high-throughput pregnane X
receptor (PXR) transactivation and binding assays. J Biomol Screen 2004;9:533–540.
REFERENCES 571